Yapei Zhang

Yapei Zhang is a Researcher at the Institute for Quantitative Health Science & Engineering within the College of Engineering at Michigan State University. Her work focuses on advancing nanomedicine, drug delivery systems, and biomaterials for applications in cancer therapy, cardiovascular disease, and biomedical imaging. She has contributed to the development of targeted nanotherapies, stimuli-responsive materials, and CRISPR delivery technologies, integrating computational modeling with experimental approaches.

Her research interests span nanomedicine, drug delivery optimization, and therapeutic genome editing. Key areas include nanoparticle design for targeted drug delivery, photoactive nanocarriers for theranostics, and magnetic hyperthermia therapies. Zhang’s studies also address atherosclerosis treatment via pro-efferocytic nanotherapies and explore the use of carbon nanotubes in imaging inflamed plaques.

Notable contributions include advances in pH-sensitive drug delivery systems, electrospun wound-healing membranes, and multimodal imaging techniques. Her work emphasizes translational applications, such as improving hypertension therapies and enhancing tumor diagnosis through nanotechnology.

While no formal awards are listed, her publications reflect a strong focus on interdisciplinary innovation at the intersection of engineering and medicine. She is affiliated with the Institute for Quantitative Health Science & Engineering, leveraging its resources for collaborative research in health science and engineering.